Use of insulin and glyburide increased in prevalence over the pregnancy period, which is likely due to a combination of newly diagnosed gestational diabetes and a switch to these treatments from other oral drugs among women with pre-existing diabetes. The gene discussed is INS; the disease is gestational diabetes.